Sunday, December 5, 2010

Cancer study boosts Genentech's Rituxan

Some blood cancer patients could use Genentech Inc.’s venerable drug Rituxan earlier to hold the cancer at bay and even shrink tumors.
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)